bexarotene has been researched along with Hodgkin Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Dreyer, S; Goh, C; Smart, C | 1 |
Helbig, D; Wirtz, M | 1 |
Bertsch, HP; Kaune, KM; Klemke, CD; Krüger, U; Mitteldorf, C; Neumann, C | 1 |
Akay, BN; Ozcan, M; Sanli, H | 1 |
4 other study(ies) available for bexarotene and Hodgkin Disease
Article | Year |
---|---|
Lichen planopilaris in a patient treated with bexarotene for lymphomatoid papulosis.
Topics: Bexarotene; Hodgkin Disease; Humans; Lichen Planus; Lymphomatoid Papulosis; Skin Neoplasms | 2020 |
[Granulomatous mycosis fungoides: combination therapy with bexarotene and PUVA].
Topics: Aged; Anticarcinogenic Agents; Bexarotene; Hodgkin Disease; Humans; Male; Mycosis Fungoides; PUVA Therapy; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome | 2014 |
Bexarotene does not prevent secondary Hodgkin's lymphoma in mycosis fungoides.
Topics: Anticarcinogenic Agents; Bexarotene; Female; Hodgkin Disease; Humans; Immunophenotyping; Middle Aged; Mycosis Fungoides; Tetrahydronaphthalenes | 2009 |
Development of Hodgkin's lymphoma under bexarotene treatment for Sézary syndrome and review of the literature.
Topics: Adult; Anticarcinogenic Agents; Bexarotene; Hodgkin Disease; Humans; Male; Sezary Syndrome; Tetrahydronaphthalenes | 2010 |